HATCH Score Calculator for Atrial Fibrillation Progression
The HATCH score (Hypertension, Age >75, TIA/Stroke, COPD, Heart failure) predicts the risk of progression from paroxysmal to persistent or permanent atrial fibrillation.
About
The HATCH score was developed by de Vos et al. and published in Chest in 2010. Derived from a cohort of 5,147 patients with paroxysmal atrial fibrillation in the Euro Heart Survey on Atrial Fibrillation, the score was designed to predict which patients would progress from paroxysmal AF (self-terminating episodes lasting ≤7 days) to persistent AF (episodes lasting >7 days requiring cardioversion) or permanent AF (accepted as ongoing). The score comprises five clinical variables weighted according to their independent predictive value: heart failure (2 points), age >75 years (1 point), prior TIA or stroke (2 points), COPD or chronic lung disease (1 point), and hypertension (1 point), for a total range of 0-7 points. The validation cohort demonstrated that patients with a HATCH score of 0-2 have a low risk (approximately 5-10%) of AF progression over 2 years, those with a score of 3-4 have a moderate risk (approximately 15-30%), and those with a score of 5-7 have a high risk (>40%). The score has been externally validated in multiple populations and remains a useful clinical tool for identifying patients who may benefit from early rhythm control strategies, including antiarrhythmic therapy or catheter ablation. The HATCH acronym makes it easily memorable for clinical use.
Formula
Heart Failure (2) + Age >75 (1) + TIA/Stroke (2) + COPD (1) + Hypertension (1)
The HATCH score is calculated by summing weighted points for five clinical variables. Heart failure (signs/symptoms of HF or LVEF ≤40%) contributes 2 points. Age >75 years contributes 1 point. Prior TIA or stroke contributes 2 points, reflecting the strongest independent predictor of AF progression. COPD or chronic lung disease contributes 1 point. Hypertension contributes 1 point. The total score ranges from 0 to 7. Higher scores indicate a greater likelihood of progression from paroxysmal to persistent or permanent AF. The score helps identify patients who may benefit from more aggressive rhythm control strategies.
Score Interpretation
The HATCH score serves as a practical clinical tool for risk-stratifying patients with paroxysmal atrial fibrillation who may progress to more advanced forms of the arrhythmia. Identifying patients at high risk for progression is clinically important because persistent and permanent AF are associated with worse outcomes, including higher stroke risk, increased heart failure hospitalizations, and lower quality of life. The score can guide decisions about early rhythm control interventions, which have been shown in trials like EAST-AFNET 4 to improve cardiovascular outcomes when initiated early in the course of AF. The HATCH score is particularly useful in primary care and general cardiology settings where it can help prioritize referrals for electrophysiology consultation and catheter ablation. While the CHADS-VASc score assesses stroke risk in AF patients, HATCH specifically addresses the arrhythmia progression trajectory and informs rhythm management strategy decisions.
Low Risk — 0–2
Low risk of AF progression (~5-10% over 2 years). Standard monitoring recommended.
Management: Monitor clinically. Annual ECG follow-up. Reassess if symptoms change.
Moderate Risk — 3–4
Moderate risk of AF progression (~15-30% over 2 years). Closer follow-up warranted.
Management: Close cardiology follow-up every 6 months. Consider 24-hour Holter monitoring. Optimize rate/rhythm control.
High Risk — 5–7
High risk of AF progression (>40% over 2 years). Early rhythm control strategy recommended.
Management: Urgent cardiology referral. Consider rhythm control (antiarrhythmics or ablation). Frequent follow-up every 3 months.
Reference Ranges
| Population | Normal Range | Notes |
|---|---|---|
| Paroxysmal AF patients | 0-7 points | Score 0-2: low risk; 3-4: moderate; 5-7: high risk of progression |
Dr. Khaled Hassan
Dr. Khaled is a cardiology consultant with 20 years of experience in managing cardiovascular patients.
View medical review board & editorial policy →Example Calculation
An 82-year-old man with paroxysmal atrial fibrillation (diagnosed 1 year ago, episodes lasting 4-6 hours every few weeks), NYHA class II heart failure (LVEF 40% on echocardiogram), hypertension (on lisinopril 10 mg daily with good control), and COPD (GOLD 2, on tiotropium). He has no prior stroke or TIA. HATCH score calculation: Heart failure (+2), Age >75 (+1), COPD (+1), Hypertension (+1) = Total 5/7, indicating high risk of AF progression. Based on this result, the patient is referred for electrophysiology consultation and catheter ablation is discussed as a rhythm control strategy to prevent progression to permanent AF and its associated complications.
Related Conditions
Related Medications
Common Mistakes
Using HATCH score to predict stroke risk instead of CHADS-VASc
HATCH predicts AF progression (paroxysmal to persistent/permanent), not stroke risk. Use CHADS-VASc for stroke risk assessment and anticoagulation decisions.
Applying HATCH score to patients with long-standing persistent AF
HATCH is designed specifically for patients with paroxysmal AF to predict progression. It has limited utility in patients who already have persistent or permanent AF.
Frequently Asked Questions
What does the HATCH score predict?
When should the HATCH score be used in clinical practice?
Can the HATCH score change over time?
How does HATCH compare to other AF risk scores?
References
- de Vos CB, Pisters R, Nieuwlaat R, et al. Progression from paroxysmal to persistent atrial fibrillation: clinical correlates and prognosis. J Am Coll Cardiol. 2010;55(8):725-731. PubMed
- de Vos CB, Pisters R, Nieuwlaat R, et al. The HATCH score for prediction of progression from paroxysmal to persistent atrial fibrillation. Chest. 2010;138(4):829-836. PubMed
- Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation. Eur Heart J. 2021;42(5):373-498. PubMed
- Kirchhof P, Camm AJ, Goette A, et al. Early Rhythm-Control Therapy in Patients with Atrial Fibrillation. N Engl J Med. 2020;383(14):1305-1316. PubMed